Cargando…
Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI
Histone deacetylases regulate a wide variety of cellular functions and have been implicated in redifferentiation of various tumors. Histone deacetylase inhibitors (HDACi) are potential pharmacologic agents to improve outcomes for patients with gliomas. We assessed the therapeutic efficacy of belinos...
Autores principales: | Gurbani, Saumya S., Yoon, Younghyoun, Weinberg, Brent D., Salgado, Eric, Press, Robert H., Cordova, J. Scott, Ramesh, Karthik K., Liang, Zhongxing, Velazquez Vega, Jose, Voloschin, Alfredo, Olson, Jeffrey J., Schreibmann, Eduard, Shim, Hyunsuk, Shu, Hui-Kuo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Grapho Publications, LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403031/ https://www.ncbi.nlm.nih.gov/pubmed/30854442 http://dx.doi.org/10.18383/j.tom.2018.00031 |
Ejemplares similares
-
Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
por: Gurbani, Saumya S, et al.
Publicado: (2020) -
Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
por: Xu, Karen, et al.
Publicado: (2022) -
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma
por: Ramesh, Karthik, et al.
Publicado: (2022) -
Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma
por: Cordova, J. Scott, et al.
Publicado: (2016) -
The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow
por: Gurbani, Saumya, et al.
Publicado: (2019)